Author

Pablo E. Companys

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Retrospective analysis of patients with locally advanced or metastatic urothelial carcinoma treated in Argentina (2018–2025): results from the GUIA 2 study in real-world clinical practice

Purpose: Urothelial carcinoma (UC) is the most common histological subtype of bladder cancer and a major public health concern. Patients from Latin America are often underrepresented in pivotal clinical trials, highlighting the importance of regional real-world evidence (RWE). This study aimed to characterise the clini...

Pablo E. Companys, Tomás Soulé, Mariano Aymar et al. · ecancermedicalscience · 0 citations

Review Open access Sep 2026

Generative Artificial Intelligence Use, Perceptions, and Expectations Among Argentine Oncology Health Care Professionals: A Cross-Sectional Survey.

GAI use was high and increasing, occurring without institutional support or formal training, and support educational program development and context-appropriate guidance for responsible adoption among oncology professionals in Argentina.

Federico Losco, A. Marchioni, E. Díaz Cantón et al. · JCO Global Oncology · 0 citations